Ozempic Cost Calculator 2026

How Much Does Ozempic Cost in 2026?

Ozempic (semaglutide) has a list price of $1,029 per month in 2026 — but that number is largely irrelevant for most patients. What you actually pay depends entirely on your insurance type, income, and whether you qualify for Novo Nordisk's savings programs. The realistic price range runs from $0 to $349/month for the overwhelming majority of patients who take the time to explore their options.

Ozempic is FDA-approved for Type 2 diabetes management. Unlike Wegovy (its obesity-focused sibling), Ozempic has broad insurance coverage because it treats a chronic disease that affects over 37 million Americans. This coverage advantage makes Ozempic one of the most accessible GLP-1 medications on the market despite its high list price.

Ozempic Pricing Scenarios in 2026

With Commercial Insurance

If your employer or marketplace insurance plan covers Ozempic (most do for T2D), your copay will typically fall between $25–$100/month depending on your formulary tier. Most plans place Ozempic on Tier 3 (preferred specialty), requiring prior authorization. Your doctor will need to submit PA documentation showing a Type 2 diabetes diagnosis, typically along with an A1C reading above 7.0%.

With the Novo Nordisk savings card applied on top of commercial insurance, many patients reduce their cost to $25/month. The savings card covers the gap between your insurance copay and its cap amount. Important: if your plan uses a copay accumulator, the savings card payment may not count toward your deductible — plan accordingly for your first few months.

NovoCare Direct — $349/Month Self-Pay

Novo Nordisk's NovoCare Pharmacy offers Ozempic directly to patients at a fixed $349/month self-pay price with a valid prescription — no insurance required, no income verification. This is a legitimate, FDA-approved branded product dispensed through a licensed pharmacy. It's the most transparent cash-pay option available and significantly below list price.

NovoCare is particularly useful for patients whose insurance doesn't cover Ozempic, those in the Medicare gap who can't use savings cards, or anyone between insurance plans. The $349/month price covers the standard monthly supply regardless of dose.

With Medicare Part D

Medicare Part D covers Ozempic for Type 2 diabetes under most plan formularies. Under the Inflation Reduction Act's $2,000 out-of-pocket cap (fully effective 2025), most Medicare enrollees pay $0–$50/month for Ozempic after the initial deductible phase. If you're in the deductible phase, you'll pay more in the first few months of the year.

Critically: you cannot use the Novo Nordisk savings card with Medicare. Using manufacturer coupons with Medicare is a federal violation. Compare Part D plans annually at Medicare.gov — formulary placement (and therefore your copay tier) varies significantly between plans.

Patient Assistance Program (Income-Based)

Patients with income below approximately 400% of the Federal Poverty Level (~$58,000 for a single person) may qualify for the Novo Nordisk Patient Assistance Program, which provides Ozempic at no cost. Your prescribing doctor must apply jointly with you. Approval typically takes 2–4 weeks, and the medication ships directly to your doctor's office or your home.

Ozempic vs. Compounded Semaglutide

Unlike Wegovy, compounded semaglutide is not an FDA-approved alternative for Ozempic specifically — Ozempic is no longer on the FDA drug shortage list as of 2026, so compounded versions are no longer legally permissible at most 503B facilities. If you're seeing "compounded Ozempic" offered at low prices through telehealth, understand that these products are not the same as branded Ozempic and carry regulatory uncertainty.

The better uninsured option for semaglutide is NovoCare direct at $349/month — same drug, FDA-approved, dispensed by Novo Nordisk's own pharmacy.

Frequently Asked Questions